HilleVax Stock (NASDAQ: HLVX) stock price, news, charts, stock research, profile.
Open | $1.80 |
Close | $1.80 |
Volume / Avg. | 816.49K / 1.10M |
Day Range | $1.77 - $1.83 |
52 Wk Range | 1.55 - 20.22 |
Market Cap | $89.69M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 25.33% |
Days to Cover | 3.74 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of HilleVax (NASDAQ:HLVX) through any online brokerage.
Other companies in HilleVax’s space includes: Renovaro (NASDAQ:RENB), CytomX Therapeutics (NASDAQ:CTMX), bluebird bio (NASDAQ:BLUE), Armata Pharmaceuticals (AMEX:ARMP) and Vistagen Therapeutics (NASDAQ:VTGN).
HilleVax has a consensus price target of $9.25.
The stock price for HilleVax (NASDAQ: HLVX) is $1.8016 last updated September 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for HilleVax.
HilleVax’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for HilleVax.
HilleVax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.